What can we learn about mega-trials of drugs?
Kala, R.
Duodecim; Laaketieteellinen Aikakauskirja 111(8): 671
1995
ISSN/ISBN: 0012-7183 PMID: 8681825 Document Number: 450313
Document emailed within 1 workday
Related Documents
Veale, D.J. 2010: What can we learn from negative clinical trials in systemic sclerosis? Clinical and Experimental Rheumatology 28(2 Suppl 58: S1-S4Rajna, P.ét. 2008: Antiepileptic drugs as mood stabilizers: what did we learn from the epileptology? Ideggyogyaszati Szemle 61(9-10): 305-316
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Del Rosso, J.Q. 2013: What more can we learn about acne and rosacea? Just keep reading, questioning, and searching for clinical relevance beyond the limitations of clinical trials Journal of Drugs in Dermatology: Jdd 12(6): 609-610
Sarnecka, B.W.; Carey, S. 2008: How counting represents number: what children must learn and when they learn it Cognition 108(3): 662-674
Lal, A.; Sharma, M.L. 1992: An assessment of clinical trials with drugs Indian Journal of Physiology and Pharmacology 36(2): 143-145
Ammann, A.J. 1999: AIDS decision threatens drugs trials Nature 397(6714): 13
Moffitt, C.M. 1998: Field trials of investigational new animal drugs Veterinary and Human Toxicology 40(Suppl): 48-52
O'Dowd, M. 2005: Learning from childhood to mature adulthood: what makes people want 'to learn to learn' and keep on learning? Compare: A Journal of Comparative and International Education 35(3): 321-338
Kale, O. 1978: Small-scale trials of six drugs against Onchocerca volvulus Tropenmedizin und Parasitologie 29(2): 163-167
Takashima, A.; Fukuda, H.; Shibata, T. 2010: Development for and clinical trials of molecular targeting drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 822-827
Peng, Y.; Li, P-ping.; Li, L.; Zhang, Y.; Hou, W-zhen.; Cui, D-dan.; Li, J.; Wang, L.; Wang, Q-li.; Wang, X-liang. 2016: Progress of clinical trials in Alzheimer's disease drugs Yao Xue Xue Bao 51(8): 1185-1195
Miller, B.L. 1980: Placebo usage in clinical trials of lifesaving drugs Progress in Clinical and Biological Research 38: 263-274
Miller, B.L. 1980: Placebo usage in clinical trials of lifesaving drugs Progress in Clinical and Biological Research 38: 263-274
Elliott, G.A. 1970: The impact of clinical trials of drugs on the investigator, the industry and the country South African Medical Journal 44(1): 5-7
Plat, F. 1992: Methodology of phase Ii clinical trials of hypocholesteremic drugs: which criteria? Archives des Maladies du Coeur et des Vaisseaux 85(Special Issue 2): 117-120
Diener, H.C. 1997: Antiplatelet drugs in secondary prevention of stroke: lessons from recent trials Neurology 49(5 Suppl. 4): S75-S81
Weissman, M.M.; Prusoff, B.A.; Klerman, G.L. 1975: Drugs and psychotherapy in depression revisited: issues in the analysis of long-term trials Psychopharmacology Bulletin 11(4): 38-39
Bartus, R.T.; Dean, R.L.; Beer, B. 1983: An evaluation of drugs for improving memory in aged monkeys: implications for clinical trials in humans Psychopharmacology Bulletin 19(2): 168-184
Skochko, O.V.; Kaĭdashev, I.P. 2012: Meta-analysis of randomized trials of antimicrobial drugs in the treatment of coronary heart disease Likars'ka Sprava 5: 72-86